Blake Gavin J, Pradhan Aruna D, Manson JoAnn E, Williams G Rhys, Buring Julie, Ridker Paul M, Glynn Robert J
Cardiovascular Division, the Center for Cardiovascular Disease Prevention, and the Division of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass, USA.
Arch Intern Med. 2004 Apr 12;164(7):757-61. doi: 10.1001/archinte.164.7.757.
Available data suggest that hemoglobin A(1c) (A(1c)), also known as glycosylated hemoglobin, levels may be related to cardiovascular risk in the general population without diabetes mellitus. We sought to test this hypothesis prospectively in a cohort of women without overt cardiovascular disease.
We conducted a nested case-control study of the Women's Health Study cohort. We identified 464 case patients with incident myocardial infarction, stroke, or coronary revascularization and 928 unmatched control subjects who remained free of cardiovascular events at case diagnosis. The mean follow-up was 7 years.
Of the overall study population, 136 had a history of diabetes mellitus or an overtly elevated baseline A(1c) level (>6.4%) and were excluded from the primary analyses. Among women without diabetes mellitus or an elevated baseline A(1c) level, mean +/- SD baseline levels of A(1c) were significantly higher among future cases than controls (5.47% +/- 0.27% vs 5.37% +/- 0.22%; P<.001). The crude relative risks (RRs) of incident cardiovascular events for increasing quartiles of A(1c) were 1.00, 0.98, 1.33, and 2.25 (95% confidence interval [CI] for the highest vs the lowest quartile, 1.59-3.18). The A(1c) levels correlated with several other traditional cardiovascular risk factors, and in fully adjusted models, the predictive effect of A(1c) was attenuated and not significant (RR for the highest vs the lowest quartile, 1.00; 95% CI, 0.65-1.54). In contrast, in the population including women with diabetes mellitus at enrollment, diabetes mellitus (RR, 4.97; 95% CI, 2.81-8.77) remained a strong independent determinant of cardiovascular risk in fully adjusted analyses, while A(1c) levels did not (RR for the highest vs the lowest quartile, 1.11; 95% CI, 0.73-1.71).
The A(1c) level is associated with future cardiovascular risk among women without diabetes mellitus, but this relationship is largely attributable to a strong correlation with other cardiovascular risk factors. In contrast, diabetes mellitus is a strong independent determinant of cardiovascular risk, even after adjustment for A(1c) levels.
现有数据表明,糖化血红蛋白A1c(A1c)水平可能与普通非糖尿病人群的心血管风险相关。我们试图在一组无明显心血管疾病的女性队列中对这一假设进行前瞻性验证。
我们对女性健康研究队列进行了一项巢式病例对照研究。我们确定了464例发生心肌梗死、中风或冠状动脉血运重建的病例患者以及928例在病例诊断时未发生心血管事件的非匹配对照受试者。平均随访时间为7年。
在整个研究人群中,136例有糖尿病病史或基线A1c水平明显升高(>6.4%),被排除在主要分析之外。在无糖尿病或基线A1c水平未升高的女性中,未来病例的A1c平均±标准差基线水平显著高于对照组(5.47%±0.27%对5.37%±0.22%;P<0.001)。A1c四分位数增加时,心血管事件发生的粗相对风险(RR)分别为1.00、0.98、1.33和2.25(最高四分位数与最低四分位数的95%置信区间[CI]为1.59 - 3.18)。A1c水平与其他几种传统心血管危险因素相关,在完全调整模型中,A1c的预测作用减弱且无统计学意义(最高四分位数与最低四分位数的RR为1.00;95%CI为0.65 - 1.54)。相比之下,在入组时包括糖尿病女性的人群中,在完全调整分析中,糖尿病(RR为4.97;95%CI为2.81 - 8.77)仍然是心血管风险的一个强有力的独立决定因素,而A1c水平则不然(最高四分位数与最低四分位数的RR为1.11;95%CI为0.73 - 1.71)。
A1c水平与无糖尿病女性未来的心血管风险相关,但这种关系很大程度上归因于与其他心血管危险因素的强相关性。相比之下,即使在调整了A1c水平后,糖尿病仍是心血管风险的一个强有力的独立决定因素。